LAMIVUDINE AND ZIDOVUDINE
Generic: LAMIVUDINE AND ZIDOVUDINE
Exelan Pharmaceuticals Inc.Manufacturer
ORALRoute
LAMIVUDINEActive Substance
2014-02-03Original Approval
LAMIVUDINE AND ZIDOVUDINE is FDA application ANDA203259, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
1,763 reports
2
VIROLOGIC FAILURE
851 reports
3
DRUG RESISTANCE
740 reports
4
EXPOSURE DURING PREGNANCY
672 reports
5
PATHOGEN RESISTANCE
663 reports
6
ANAEMIA
642 reports
7
VIRAL MUTATION IDENTIFIED
637 reports
8
DRUG EXPOSURE DURING PREGNANCY
599 reports
9
PREMATURE BABY
536 reports
10
MATERNAL EXPOSURE DURING PREGNANCY
531 reports